Search results
10 sty 2024 · To guide clinicians and policymakers in three global resource-constrained settings on treating patients with metastatic breast cancer (MBC) when Maximal setting–guideline recommended treatment is unavailable. Methods.
6 sie 2019 · In patients with HER2-positive early breast cancer with positive lymph nodes and/or ER negativity, pertuzumab in addition to trastuzumab and chemotherapy improved invasive disease-free survival (AGO+).
1 wrz 2021 · Metastatic lymph node involvement in breast cancer is a key determinant of the overall stage of disease and prognosis. Historically, lymph node status was determined by surgery first, with adjuvant treatments determined based on the results of the final surgical pathologic analysis.
28 lip 2021 · The hazard ratio for contralateral breast cancer was 1.15 (95% CI, 0.75 to 1.77) (Fig. S1A), and the hazard ratio for a second primary cancer was 1.06 (95% CI, 0.81 to 1.38) (Fig....
Women with stage IV breast cancer are most often treated with hormone therapy, chemotherapy, targeted therapy, immunotherapy, or some combination of these. Surgery or radiation might be used to help prevent or treat symptoms.
19 cze 2023 · Practical Applications. •Triple-negative breast cancer (TNBC) remains the most challenging breast cancer subtype to treat because of its aggressive phenotype and limited treatment options. •Neoadjuvant chemotherapy is the preferred approach to treat stage II or III TNBC.
20 mar 2020 · Treatment strategies for breast cancer are wide-ranging and often based on a multi-modality approach, depending on the stage and biology of the tumour and the acceptance and tolerance of the patient. They may include surgery, radiotherapy, and systemic therapy (endocrine therapy, chemotherapy, and targeted therapy).
